CAY10722 – 5 mg

Brand:
Cayman
CAS:
388086-13-3
Storage:
-20
UN-No:
Non-Hazardous - /

CAY10722 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (71% inhibition at 200 µM).{39002} SIRT3 is involved in modulating metabolic homeostasis as a NAD+-dependent protein deacetylase in the mitochondria. SIRT3 functions as either an oncogene or tumor suppressor, depending on cancer cell type.{39000,39003} High SIRT3 expression in patient-derived esophageal cancer tissues is associated with shorter survival and, in mice, downregulation leads to a lower tumor load.{39004} In contrast, low SIRT3 expression in patient-derived breast cancer cells is correlated with shorter survival.{39001}  

 

Out of stock

SKU: 22404 - Category:

Description

An inhibitor of SIRT3, a class III HDAC (71% inhibition at 200 µM),


Formal name: N-[2-(2,4-dichlorophenyl)-5-benzoxazolyl]-benzeneacetamide

Synonyms: 

Molecular weight: 397.3

CAS: 388086-13-3

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation